EUVIMEDEUVIMED entdecken
Crossref

PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study

The Egyptian Journal of Hospital Medicine · 01.07.2026 · 104 (1) · 4605-4613

DOI: 10.21608/ejhm.2026.522607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.07.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study. The Egyptian Journal of Hospital Medicine, 104(1), 4605-4613. https://doi.org/10.21608/ejhm.2026.522607

Vancouver

PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study. The Egyptian Journal of Hospital Medicine. 2026;104(1):4605-4613. doi:10.21608/ejhm.2026.522607

BibTeX
@article{euvimed2026,
  title = {PD-1 Expression in Tumor-Infiltrating Lymphocytes as a Biomarker in Pancreatic Ductal Adenocarcinoma: An Immunohistochemical and Clinicopathological Correlation Study},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {104},
  number = {1},
  pages = {4605--4613},
  doi = {10.21608/ejhm.2026.522607}
}
Kostenlos starten →